[ad_1] Abbott launches over-the-counter glucose monitor, Lingo [ad_2] Source: Seekingalpha
Browsing: Healthcare
[ad_1] McKesson slips as Q2 outlook underwhelms [ad_2] Source: Seekingalpha
[ad_1] Perspective gets FDA fast track status for radiopharmaceutical VMT01 [ad_2] Source: Seekingalpha
[ad_1] Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket [ad_2] Source: Seekingalpha
[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha
[ad_1] Lisata jumps on FDA orphan drug status for liver cancer drug [ad_2] Source: Seekingalpha
[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
[ad_1] Vor Bio stock rallies post-market on trem-cel study data [ad_2] Source: Seekingalpha
[ad_1] aTyr started at buy by Jefferies, citing efzofitimod potential [ad_2] Source: Seekingalpha
[ad_1] Kits Eyecare announces $10.15M secondary offering [ad_2] Source: Seekingalpha
